Application of bioactive materials primary cilia as a novel delivery vehicle
Source abstract
Abstract
Primary cilia are hair-like structured cell organelles functioning as cellular antennae with chemosensory and mechanosensory roles. Dysfunction of cilia results in ciliopathies, including renovascular diseases (polycystic kidneys, hypertension, aneurysm), mental impedances (Alzheimer's disease, Parkinson's disease, dementia), metabolic diseases (obesity, developmental skeleton defects), blindness, and so on. With a diameter of 150 nm, cilia can be cleaved, released and circulated in the body as injury biomarkers. We here assessed the potential use of isolated cilia as a novel delivery vehicle. Cilia were isolated from renal epithelial cells, and a specific-targeting chemotherapeutic was designed on the cilia. The data show a remarkable property of cilia to significantly inhibit disease progression with reduced toxicity. These findings emphasize the prospective biomedical applications of primary cilia in generating novel drug, gene, protein, and other delivery systems to treat diverse pathological conditions. While there are many synthetic drug delivery vehicles, our studies demonstrate for the first time that physiologically produced primary cilia can be adapted as a unique carrier system.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Genetic and Kidney Cyst Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Kar · ACS Biomater. Sci. Eng. · 2023 · 9 · 57710.1021/acsbiomaterials.2c01329 ↗
2. Mill · Nat. Rev. Genet. · 2023 · 24 · 42110.1038/s41576-023-00587-9 ↗
3. Mohieldin · Adv. Sci. (Weinh.) · 2020 · 7
4. Mirvis · PLoS Biol. · 2019 · 1710.1371/journal.pbio.3000381 ↗
5. Phua · Cell · 2019 · 178 · 26110.1016/j.cell.2019.06.015 ↗
6. Ramchandran · Front. Cell Dev. Biol. · 2022 · 1010.3389/fcell.2022.994133 ↗
7. Gupta · JCI Insight · 2022 · 710.1172/jci.insight.151813 ↗
8. Mohieldin · J. Extracell. Vesicles · 2021 · 1010.1002/jev2.12086 ↗
9. Bielas · Nat. Genet. · 2009 · 41 · 103210.1038/ng.423 ↗
10. Jacoby · Nat. Genet. · 2009 · 41 · 102710.1038/ng.427 ↗
11. Mohieldin · Cell. Mol. Life Sci. · 2015 · 72 · 241510.1007/s00018-015-1838-x ↗
12. Mitchell · Curr. Protoc. Cell Biol. · 2013 · 5910.1002/0471143030.cb0342s59 ↗
13. Wu · Adv. Drug Deliv. Rev. · 2011 · 63 · 45610.1016/j.addr.2011.02.001 ↗
14. AbouAitah · Oncotarget · 2018 · 910.18632/oncotarget.25470 ↗
15. Cafaggi · J. Contr. Release · 2007 · 121 · 11010.1016/j.jconrel.2007.05.037 ↗
16. Verma · Pharm. Res. · 2019 · 36 · 12310.1007/s11095-019-2653-0 ↗
17. Jain · J. Nano Res. · 2013 · 15 · 177210.1007/s11051-013-1772-5 ↗
18. Chen · J. Mater. Chem. B · 2015 · 3 · 894910.1039/C5TB01851J ↗
19. Kim · RSC Adv. · 2022 · 12
20. Aouali · Int. J. Oncol. · 2003 · 23 · 1195
21. Goto · FASEB J. · 2001 · 15 · 270210.1096/fj.01-0376com ↗
22. Stack · Nanoscale Horiz · 2021 · 6 · 39310.1039/D0NH00679C ↗
23. Kazi · Medchemcomm · 2019 · 10 · 55910.1039/C8MD00565F ↗
24. Zhang · Nat. Med. · 2012 · 18 · 163910.1038/nm.2919 ↗
25. Mitchell · Nat. Rev. Drug Discov. · 2021 · 20 · 10110.1038/s41573-020-0090-8 ↗
26. Uxa · Cell Death Differ. · 2021 · 28 · 335710.1038/s41418-021-00823-x ↗
27. Thangarajah · Anticancer Res. · 2017 · 37 · 195710.21873/anticanres.11536 ↗
28. Wang · Biotech. Histochem. · 2008 · 83 · 17910.1080/10520290802451085 ↗
29. Righi · Am. J. Pathol. · 2003 · 162 · 116310.1016/S0002-9440(10)63912-0 ↗
30. Li · Mol. Med. Rep. · 2015 · 11 · 156610.3892/mmr.2014.2914 ↗
31. Tan · Mod. Pathol. · 2005 · 18 · 37410.1038/modpathol.3800254 ↗
32. Das · Nanoscale · 2020 · 12 · 760410.1039/D0NR00631A ↗
33. Brown · Nat. Med. · 2001 · 7 · 86410.1038/89997 ↗
34. Jain · Cancer Res. · 1988 · 48 · 2641
35. Almagro · Trends Cancer · 2022 · 8 · 49410.1016/j.trecan.2022.02.007 ↗
36. Junttila · Front. Immunol. · 2018 · 9 · 88810.3389/fimmu.2018.00888 ↗
37. Finkelman · J. Immunol. · 1988 · 141 · 233510.4049/jimmunol.141.7.2335 ↗
38. Tanaka · Cold Spring Harbor Perspect. Biol. · 2014 · 610.1101/cshperspect.a016295 ↗
39. Parameswaran · Crit. Rev. Eukaryot. Gene Expr. · 2010 · 20 · 8710.1615/CritRevEukarGeneExpr.v20.i2.10 ↗
40. Elsharkasy · Adv. Drug Deliv. Rev. · 2020 · 159 · 33210.1016/j.addr.2020.04.004 ↗
41. Sercombe · Front. Pharmacol. · 2015 · 6 · 28610.3389/fphar.2015.00286 ↗
42. de Jong · Acc. Chem. Res. · 2019 · 52 · 176110.1021/acs.accounts.9b00109 ↗
43. Storm · Clin. Cancer Res. · 1998 · 4 · 111
44. Ou · Annu. Rev. Cell Dev. Biol. · 2022 · 38 · 4910.1146/annurev-cellbio-121420-100107 ↗
45. Pala · ACS Nano · 2019 · 13 · 355510.1021/acsnano.9b00033 ↗
46. Pala · Nano Lett. · 2019 · 19 · 90410.1021/acs.nanolett.8b04138 ↗
47. Mitchell · Methods Cell Biol. · 2009 · 94 · 8710.1016/S0091-679X(08)94004-8 ↗
48. Morishita · J. Pharmaceut. Sci. · 2015 · 104 · 70510.1002/jps.24251 ↗